Keratin 19-positive cutaneous squamous cell carcinoma with elevated serum cytokeratin 19 fragment 21-1 level: A case report

被引:2
|
作者
Ueda, Misato [1 ]
Yasuda, Michinori [1 ]
Shibaoka, Yoshie [1 ]
Kurokawa, Ichiro [2 ]
Kakuno, Ayako [3 ]
Tsubura, Airo [4 ]
机构
[1] Meiwa Hosp, Dept Plast & Reconstruct Surg, Nishinomiya, Hyogo 6638186, Japan
[2] Meiwa Hosp, Dept Dermatol, 4-31 Agenaruo Cho, Nishinomiya, Hyogo 6638186, Japan
[3] Meiwa Hosp, Dept Pathol, Nishinomiya, Hyogo 6638186, Japan
[4] Kansai Med Univ, Dept Pathol, Nishinomiya, Hyogo 6638186, Japan
关键词
cytokeratin; 19; fragment; 21-1; keratin; primary cutaneous squamous cell carcinoma;
D O I
10.3892/mco.2016.834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytokeratin 19 fragment 21-1 (CYFRA21-1) is a marker of lung cancer useful for evaluating clinical diagnosis and prognosis. To the best of our knowledge, there have been no reports of cutaneous squamous cell carcinoma (SCC) with high levels of CYFRA21-1 to date. We herein report a case of a 79-year-old man with a large subcutaneous tumor of the left shoulder, which was diagnosed as primary cutaneous poorly differentiated SCC. The tumor nests were composed of poorly differentiated atypical squamous cells exhibiting high-grade malignancy and mitotic figures; multinuclear cells were also identified inside lymph vessels. Keratin 19 (K19) was intensely expressed in tumor cells. A significantly elevated level of CYFRA21-1 (33 ng/ml) was observed preoperatively. After surgery, the level of CYFRA21-1 was significantly decreased (from 33 to 5.0 ng/ml). Our case demonstrated that K19-positive primary cutaneous undifferentiated SCC induced high levels of CYFRA21-1 in the serum. Thus, CYFRA 21-1 may be a marker indicative of poorly differentiated cutaneous SCC exhibiting K19 expression.
引用
收藏
页码:986 / 988
页数:3
相关论文
共 50 条
  • [21] The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix
    Liu, Chan-zhen
    Zeng, Hao-xia
    Zhao, Jing-jing
    Rong, Yan
    Mo, Zhe-lun
    Li, Li A.
    Zhang, Jie-qing
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (05) : 994 - 1000
  • [22] Clinical significance of serum cytokeratin 19 fragment (CYFRA 21-1) in biliary tract cancers: a reliable biomarker for gallbladder carcinoma and intrahepatic cholangiocarcinoma
    Huang, Li
    Chen, Wei
    Liang, Peiwen
    Hu, Wenjie
    Zhang, Kunsong
    Chen, Bin
    Han, Yuyan
    Meng, Fanyin
    DeMorrow, Sharon
    Yin, Xiaoyu
    Lai, Jiaming
    Liang, Lijian
    HEPATOLOGY, 2014, 60 : 799A - 799A
  • [23] Biochemical analysis of cytokeratin fragment 21-1 concentration and expression of cytokeratin 19 in oral potentially malignant disorders
    Rathore, Ajit Singh
    Katyal, Sonal
    Jain, Anshi
    Shetty, Devi Charan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (03) : 452 - 457
  • [24] Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma
    Sun, SS
    Hsieh, JF
    Tsai, SC
    Ho, YJ
    Lee, JK
    Kao, CH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (03): : 241 - 243
  • [25] Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients
    Pierga, JY
    Deneux, L
    Bonneton, C
    Vincent-Salomon, A
    Nos, C
    Anract, P
    Magdelénat, H
    Pouillart, P
    Thiery, JP
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (01): : 23 - 31
  • [26] Increased Circulating Cytokeratin-19 (Cyfra 21-1) is Predictive of Poor Outcome of Locally Advanced Squamous Cell Carcinoma in Lung
    Wang, Jingbo
    Ji, Zhe
    Cao, Jianzhong
    Ma, Yan
    Jiang, Wei
    Liu, Lipin
    Men, Yu
    Xu, Cai
    Wang, Xiaozhen
    Hui, Zhou Guang
    Liang, Jun
    Lv, Jima
    Zhou, Zongmei
    Xiao, Zefen
    Feng, Qinfu
    Chen, Dongfu
    Zhang, Hongxing
    Yin, Weibo
    Wang, Luhua
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S847 - S848
  • [27] Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion
    Lai, RS
    Chen, CC
    Lee, PC
    Lu, JY
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (09) : 421 - 424
  • [28] Reference Intervals of Cytokeratin-19 Fragment (CYFRA 21-1) in Healthy Adults in China
    Dai, Yunhai
    Qu, Wei
    Sang, Shibiao
    Tao, Shaoneng
    Li, Yan
    Wang, Yan
    Li, Qingru
    Wu, Tingting
    Zhu, Anyou
    Chen, Qing
    Song, Jiaqi
    Li, Qing
    Ji, Yongliang
    Zheng, Yijie
    Wang, Fengchao
    CLINICAL LABORATORY, 2018, 64 (1-2) : 123 - 133
  • [29] Serum cytokeratin-19 fragments (CYFRA 21-1) for the prediction of overall survival in patients with hepatocellular carcinoma
    Caviglia, Gian Paolo
    Olivero, Antonella
    Ciruolo, Michela
    Carucci, Patrizia
    Rolle, Emanuela
    Rosso, Chiara
    Abate, Maria Lorena
    Risso, Alessandra
    Younes, Ramy
    Smedile, Antonina
    Saracco, Giorgio Maria
    Bugianesi, Elisabetta
    Gaia, Silvia
    JOURNAL OF HEPATOLOGY, 2020, 73 : S372 - S373
  • [30] Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma
    Kato, J.
    Hida, T.
    Sugita, S.
    Hasegawa, T.
    Kamiya, S.
    Horimoto, K.
    Sato, S.
    Sawada, M.
    Uhara, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : E299 - E301